Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 9 of 9 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GUSELKUMAB (Tremfya (TN)) | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬1. GUSELKUMAB
| 1件: IL23A IL23A 💬1. GUSELKUMAB
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 5件: 37 37, 41, 51, 96, 97 💬
| ||||||||||||||
| 2 | Guselkumab 100 mg (Tremfya (TN)) | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬2. Guselkumab 100 mg
| 1件: IL23A IL23A 💬2. Guselkumab 100 mg
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 1件: 37 37 💬2. Guselkumab 100 mg
| ||||||||||||||
| 3 | Guselkumab Dose 1 (Tremfya (TN)) | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬3. Guselkumab Dose 1
| 1件: IL23A IL23A 💬3. Guselkumab Dose 1
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 3件: 51 51, 96, 97 💬
| ||||||||||||||
| 4 | Guselkumab Dose 2 (Tremfya (TN)) | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬4. Guselkumab Dose 2
| 1件: IL23A IL23A 💬4. Guselkumab Dose 2
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 3件: 51 51, 96, 97 💬
| ||||||||||||||
| 5 | Guselkumab Dose 3 (Tremfya (TN)) | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬5. Guselkumab Dose 3
| 1件: IL23A IL23A 💬5. Guselkumab Dose 3
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 2件: 96 96, 97 💬
| ||||||||||||||
| 6 | Guselkumab Dose 4 (Tremfya (TN)) | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬6. Guselkumab Dose 4
| 1件: IL23A IL23A 💬6. Guselkumab Dose 4
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 1件: 96 96 💬6. Guselkumab Dose 4
| ||||||||||||||
| 7 | Guselkumab Dose 5 (Tremfya (TN)) | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬7. Guselkumab Dose 5
| 1件: IL23A IL23A 💬7. Guselkumab Dose 5
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 1件: 96 96 💬7. Guselkumab Dose 5
| ||||||||||||||
| 8 | TREMFYA | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬8. TREMFYA
| 1件: IL23A IL23A 💬8. TREMFYA
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 2件: 37 37, 97 💬
| ||||||||||||||
| 9 | TREMFYA® | 1件: Guselkumab Guselkumab (Tremfya) | 1件: Guselkumab
Guselkumab
(Tremfya (TN)) 💬9. TREMFYA®
| 1件: IL23A IL23A 💬9. TREMFYA®
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory b ... | 2件: 37 37, 97 💬
|